SKI Market

Indian Indices

Nifty

26,175.75 -27.20
(-0.10%)

Sensex

85,237.13 -404.77
( -0.47%)

Bank Nifty

59,681.35 -71.35
( -0.12%)

Nifty IT

37,549.75 144.25
( 0.39%)

Global Indices

Nasdaq

47,322.89 -414.54
(-0.87%)

Dow Jones

6,835.10 -34.99
(-0.51%)

Hang Seng

49,313.21 -940.70
(-1.87%)

Nikkei 225

9,706.88 -13.63
(-0.14%)

Forex

USD-INR

89.34 0.04
(0.05%)

EUR-INR

103.59 0.05
(0.05%)

GBP-INR

118.16 -0.07
(-0.06%)

JPY-INR

0.57 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.68

123088.18

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.05

Back

Cipla consolidated net profit rises 3.73% in the September 2025 quarter

Oct 30,2025

Net profit of Cipla rose 3.73% to Rs 1351.17 crore in the quarter ended September 2025 as against Rs 1302.53 crore during the previous quarter ended September 2024. Sales rose 6.98% to Rs 7447.42 crore in the quarter ended September 2025 as against Rs 6961.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7447.42	6961.22	7
OPM %	25.44	27.09	-
PBDT	2150.52	2060.80	4
PBT	1853.53	1789.06	4
NP	1351.17	1302.53	4

26,175.75 -27.20 (-0.10%)

85,237.13 -404.77 ( -0.47%)

59,681.35 -71.35 ( -0.12%)

37,549.75 144.25 ( 0.39%)

47,322.89 -414.54 (-0.87%)

6,835.10 -34.99 (-0.51%)

49,313.21 -940.70 (-1.87%)

9,706.88 -13.63 (-0.14%)

89.34 0.04 (0.05%)

103.59 0.05 (0.05%)

118.16 -0.07 (-0.06%)

0.57 0.00 (0.06%)